$175K in pilot grants awarded to UC cancer researchers
Pilot grants totaling $175,000 were recently awarded to University of Cincinnati (UC) researchers to fund projects dedicated to advancing science and finding new therapies for pancreatic and head and neck cancers.
Xiaoyang Qi, PhD, and Fukun Guo, PhD
GIVEHOPE Pancreatic Cancer Research and Awareness Fund:
$47,500 to Xiaoyang Qi, PhD, professor in the Division of Hematology Oncology, member of the Cincinnati Cancer Center and UC Cancer Institute. Qi and his team will study a cellular structure and function in metastatic pancreatic cancer cells and determine the therapeutic efficacy of nanovesicles by blocking certain cancer-causing pathways in cancer development and spread.
$47,500 to Fukun Guo, PhD, associate professor in the Department of Pediatrics and a researcher at Cincinnati Children’s. Guo and his team will determine the efficacy of chemical targeting of animal and human regulatory T cells (a type of white blood cells) as a way to trigger immunity against pancreatic tumor formation.
Yana Zavros, PhD
Steven Goldman Memorial Pancreatic Cancer Research Grant:
$55,000 to Yana Zavros, PhD, professor in the Department of Pharmacology and Systems Physiology, and her team. As Zavros received funds from the Goldman grant last year, her continuing project will focus on putting individual pancreatic cancer patient immune cells into an organoid culture to predict the best treatment for that person. An organoid is a three-dimensional, multicellular miniaturized version of the tissue or organ from which it was derived. The hope is that this personalized assessment will improve outcomes for patients.
Vinita Takiar, MD, PhD
Brandon C. Gromada Head and Neck Cancer Foundation Research Fund:
$25,000 to Vinita Takiar, MD, PhD, assistant professor in the Department of Radiation Oncology and member of the UC Cancer Institute, and her multidisciplinary team including medical oncologist Trisha Wise-Draper, MD, surgeon Alice Tang, MD, and post-doctoral fellow Christina Wicker, PhD. Their project will collect pilot data for a new approach to treatment of head and neck cancers by looking first at patient-derived organoids. Growing tumors in the lab directly from patients will provide the researchers with a new way to study head and neck cancers and test treatment options.
Related Stories
Taking a second look at surgery eligibility for patients with lung cancer who smoke
June 11, 2026
Researchers at the University of Cincinnati College of Medicine have found that patients who continue to smoke ahead of lung cancer surgery have a higher risk of pulmonary complications, but their short-term mortality rate is similar to patients who were able to stop smoking before surgery.. Their findings were published recently in the Journal of. American College of Surgeons
Pocket-sized population threat
June 10, 2026
The Financial Times took a deep dive into why populations around the world continue to be on the decline. The publication cited new University of Cincinnati research as part of the investigation that looks at the fall of fertility in the digital era.
UC Klekamp Law celebrates the 2026 Distinguished Alumni
June 10, 2026
The UC Klekamp College of Law honors the 2026 Distinguished Alumni who exemplify leadership, service, innovation and impact.